Classification of Apolipoprotein E ϵ4 Allele Carriers in Alzheimer Disease Patients and Healthy Controls using Event‐Related Potentials and Event‐Related Spectral Perturbation

Abstract Background Understanding the genetic etiology of Alzheimer's disease (AD) has been a major focus of research in neurodegenerative diseases. Amid the three common allelic variants of the apolipoprotein E (APOE) gene in humans, called APOE ε2, ε3 and ε4, the ε4 allele is the most common genetic risk factor for late‐onset AD, being found in 20% of the world population. Method We used Event‐Related Potentials (ERP) and Event‐Related Spectral Perturbation (ERSP) as features for classification of apolipoprotein E ϵ4 (APOE ε4) allele carriers in AD patients and healthy controls. The study participants were 37 healthy older adults (9 APOE ε4 carriers) and 47 AD patients (15 APOE ε4 carriers), which underwent an auditory oddball task (with Target and Frequent trials) using an electroencephalographic (EEG) equipment with 21 channels. A leave‐one‐subject‐out (LOSO) cross‐validation approach was used to perform feature selection and classification with Support Vector Machine (SVM) classifiers. Result After feature extraction and selection, we achieved a classification accuracy of 86,90% in the APOE ε4 carriers versus non‐carriers comparison (regardless diagnosis) and 85,71% in the Alzheimer disease patients versus healthy controls comparison (regardless APOE ε4 status). When combining the results of all participants we reached a global accuracy of 73,81% in the four‐class classification (Alzheimer disease patients carriers and non‐carriers, healthy elderly carriers and non‐carriers). Conclusion We hope our work could help clinicians to make a more accurate and earlier AD diagnosis, considering the presence of the APOE ε4 allele.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.084919
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Classification of Apolipoprotein E ϵ4 Allele Carriers in Alzheimer Disease Patients and Healthy Controls using Event‐Related Potentials and Event‐Related Spectral Perturbation

Francisco J. Fraga, Márcia R. Cominetti, Sebastião Martins Filho, Henrique Pott et al.
Alzheimer s & Dementia
Computational Drug Discovery Methods
article

Classification of Apolipoprotein E ϵ4 Allele Carriers in Alzheimer Disease Patients and Healthy Controls using Event‐Related Potentials and Event‐Related Spectral Perturbation

Francisco J. Fraga, Márcia R. Cominetti, Sebastião Martins Filho, Henrique Pott, Carla Manuela Crispim Nascimento, Renata Valle Pedroso, Kauê O. Frassão
article en

Abstract

Abstract Background Understanding the genetic etiology of Alzheimer's disease (AD) has been a major focus of research in neurodegenerative diseases. Amid the three common allelic variants of the apolipoprotein E (APOE) gene in humans, called APOE ε2, ε3 and ε4, the ε4 allele is the most common genetic risk factor for late‐onset AD, being found in 20% of the world population. Method We used Event‐Related Potentials (ERP) and Event‐Related Spectral Perturbation (ERSP) as features for classification of apolipoprotein E ϵ4 (APOE ε4) allele carriers in AD patients and healthy controls. The study participants were 37 healthy older adults (9 APOE ε4 carriers) and 47 AD patients (15 APOE ε4 carriers), which underwent an auditory oddball task (with Target and Frequent trials) using an electroencephalographic (EEG) equipment with 21 channels. A leave‐one‐subject‐out (LOSO) cross‐validation approach was used to perform feature selection and classification with Support Vector Machine (SVM) classifiers. Result After feature extraction and selection, we achieved a classification accuracy of 86,90% in the APOE ε4 carriers versus non‐carriers comparison (regardless diagnosis) and 85,71% in the Alzheimer disease patients versus healthy controls comparison (regardless APOE ε4 status). When combining the results of all participants we reached a global accuracy of 73,81% in the four‐class classification (Alzheimer disease patients carriers and non‐carriers, healthy elderly carriers and non‐carriers). Conclusion We hope our work could help clinicians to make a more accurate and earlier AD diagnosis, considering the presence of the APOE ε4 allele.

Alzheimer s & DementiaVol. 20(S2)
Universidade Federal de São Carlos (BR), Instituto de Neurociencias (ES), Universidade Federal do ABC (BR)
Openalex Percentile: Top 70%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.